Evidence map›Paper›PMID 37443734›Full record

ArticleCells2023

A Shared Pathogenic Mechanism for Valproic Acid and

Taylor N Takla, Jinghui Luo, Roksolana Sudyk, Joy Huang, John Clayton Walker, Neeta L Vora, Jonathan Z Sexton, Jack M Parent, Andrew M Tidball

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Human Brain Organoids: Development and Applications.Journal of microbiology and biotechnology · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Brain organoid protocols and limitations.Frontiers in cellular neuroscience · 2024
    Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Taylor N TaklaDepartment of Neurology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
Jinghui LuoDepartment of Neurology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
Roksolana SudykDepartment of Neurology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
Joy HuangDepartment of Neurology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
John Clayton WalkerDepartment of Neurology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
Neeta L VoraDepartment of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0002-2504-9455
Jonathan Z SextonDepartment of Internal Medicine, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
Jack M ParentDepartment of Neurology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.
Andrew M TidballDepartment of Neurology, Medical School, University of Michigan, Ann Arbor, MI 48109, USA.ORCID 0000-0002-1666-4106
University of Michigan · USUniversity of North Carolina at Chapel Hill · US

Funding

Modeling genetic anencephaly with human brain organoidsR03HD104901 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TIDBALL, ANDREW M · 2022 to 2023
$248k
Evaluating teratogenic risk of anti-seizure medications in single-rosette brain organoidsR21HD106580 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TIDBALL, ANDREW M · 2021 to 2022
$215k
NICHD NIH HHS R03 HD104901NICHD NIH HHS R21 HD106580
6 · The paper itself

Abstract

Neural tube defects (NTDs), including anencephaly and spina bifida, are common major malformations of fetal development resulting from incomplete closure of the neural tube. These conditions lead to either universal death (anencephaly) or severe lifelong complications (spina bifida). Despite hundreds of genetic mouse models of neural tube defect phenotypes, the genetics of human NTDs are poorly understood. Furthermore, pharmaceuticals, such as antiseizure medications, have been found clinically to increase the risk of NTDs when administered during pregnancy. Therefore, a model that recapitulates human neurodevelopment would be of immense benefit to understand the genetics underlying NTDs and identify teratogenic mechanisms. Using our self-organizing single rosette cortical organoid (SOSR-COs) system, we have developed a high-throughput image analysis pipeline for evaluating the SOSR-CO structure for NTD-like phenotypes. Similar to small molecule inhibition of apical constriction, the antiseizure medication valproic acid (VPA), a known cause of NTDs, increases the apical lumen size and apical cell surface area in a dose-responsive manner. GSK3β and HDAC inhibitors caused similar lumen expansion; however, RNA sequencing suggests VPA does not inhibit GSK3β at these concentrations. The knockout of

Indexed as

AnencephalyNeural Tube DefectsSpinal DysraphismAnimalsBrainFemaleGlycogen Synthase Kinase 3 betaHumansMiceMice, KnockoutMicrofilament ProteinsPregnancyValproic AcidGlycogen Synthase Kinase 3 betaMicrofilament ProteinsSHROOM3 protein, humanValproic Acidanencephalyinduced pluripotent stem cellsneuroteratogen

Identifiers

PMID37443734
PMCPMC10340169
OpenAlexW4382137556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.